01 2NovoEight
02 1of which Novoeight
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 238
2019 Revenue in Millions : 248
Growth (%) : -4
Main Therapeutic Indication : Blood Disorders
Currency : USD
2018 Revenue in Millions : 203
2017 Revenue in Millions : 165
Growth (%) : 23%
Main Therapeutic Indication : Hematology
Currency : USD
2019 Revenue in Millions : 229
2018 Revenue in Millions : 203
Growth (%) : 13
